Sacral neuromodulation versus onabotulinumtoxinA for refractory urgency urinary incontinence: impact on fecal incontinence symptoms and sexual function.

ABSTRACT:

Background

Women with refractory urgency urinary incontinence can be treated with onabotulinumtoxinA or sacral neuromodulation. Little data exists on the comparative effects of treatment of refractory urgency urinary incontinence on other pelvic floor complaints, such as bowel and sexual function.

Objective

The objective of this study was to compare the impact of these treatments on fecal incontinence and sexual symptoms.

Methods

This was a planned supplemental analysis of a randomized trial in women with refractory urgency urinary incontinence treated with onabotulinumtoxinA (n = 190) or sacral neuromodulation (n = 174). Fecal incontinence and sexual symptoms were assessed at baseline and at 6, 12, and 24 months. Fecal incontinence symptoms were measured using the St

SUBMITTER: Andy UU 

PROVIDER: S-EPMC6911169 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature